Intelligent Medicine Acquisition Corp (IQMD) Peer Comparison
$11.04
$0.00 (0.00%)As on 10-May-2023 09:30EDT
Market cap
$65 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
23
P/B Ratio
0
Div. Yield
0 %
Edit
| Intelligent Medicine Acquisition Corp (IQMD) | Kimbell Tiger Acquisition Corp (TGR-UN) | Kimbell Tiger Acquisition Corp (TGR) | B Riley Principal 250 Merger Corp (BRIV) | |
|---|---|---|---|---|
Market cap ($ Mln) |
65 | -- | 303 | 226 |
Revenue ($ Mln) |
-- | -- | -- | -- |
Net Profit ($ Mln) |
9.88 | 5.20 | 3.88 | 5.58 |
Net Margin (%) |
114.93 | -- | 100.65 | 105.83 |
RoE (%) |
4.91 | 2.18 | 1.69 | 3.21 |
Price to Earnings |
23.00 | -- | 263.75 | 40.74 |
Price-To-Book |
-- | -- | -- | 1.27 |
Income Statement ($ Mln)
| Intelligent Medicine Acquisition Corp (IQMD) | Kimbell Tiger Acquisition Corp (TGR-UN) | Kimbell Tiger Acquisition Corp (TGR) | B Riley Principal 250 Merger Corp (BRIV) | |
|---|---|---|---|---|
|
Operating Revenue
|
0.00 | 0.00 | 0.00 | 0.00 |
|
Cost of Revenue
|
0.00 | 0.00 | 0.00 | 1.75 |
|
Gross Profit
|
-- | -- | -- | -1.18 |
|
Operating Expenses
|
1.30 | 1.81 | 1.81 | 1.13 |
|
Operating Profit (EBIT)
|
-9.90 | -4.47 | -4.47 | -1.13 |
|
Other Income
|
8.59 | 0.00 | 3.85 | 5.28 |
|
Profit before Tax
|
10.73 | 4.24 | 4.24 | 6.40 |
|
Provision for Tax
|
0.56 | -1.09 | 0.10 | 0.45 |
|
Profit after Tax (Net Income)
|
9.88 | 5.20 | 3.88 | 5.58 |
|
Minority Interest
|
0.00 | -0.15 | 0.04 | 0.00 |
|
Consolidated Profit
|
7.04 | 0.00 | 1.94 | 3.97 |
Liabilities ($ Mln)
| Intelligent Medicine Acquisition Corp (IQMD) | Kimbell Tiger Acquisition Corp (TGR-UN) | Kimbell Tiger Acquisition Corp (TGR) | B Riley Principal 250 Merger Corp (BRIV) | |
|---|---|---|---|---|
|
Shareholder's Funds
|
202.40 | 233.44 | 233.44 | 174.61 |
|
Minority Interest
|
0.00 | -0.15 | 0.04 | 0.00 |
|
Non-Current Liabilities
|
10.56 | 237.01 | 237.01 | 0.18 |
|
Current Liabilities
|
1.08 | 9.69 | 9.69 | 0.81 |
|
Total Liabilities
|
214.03 | 241.05 | 241.05 | 175.60 |
Assets ($ Mln)
| Intelligent Medicine Acquisition Corp (IQMD) | Kimbell Tiger Acquisition Corp (TGR-UN) | Kimbell Tiger Acquisition Corp (TGR) | B Riley Principal 250 Merger Corp (BRIV) | |
|---|---|---|---|---|
|
Non-Current Assets
|
213.85 | 0.00 | 0.00 | 174.44 |
|
Current Assets
|
0.19 | 243.24 | 243.24 | 1.16 |
|
Total Assets
|
214.03 | 241.05 | 241.05 | 175.60 |
|
Total Debt*
|
0.00 | 0.00 | 0.00 | 0.00 |
|
Net Current Assets
|
0.00 | 233.55 | 233.55 | 0.00 |
Cashflow ($ Mln)
| Intelligent Medicine Acquisition Corp (IQMD) | Kimbell Tiger Acquisition Corp (TGR-UN) | Kimbell Tiger Acquisition Corp (TGR) | B Riley Principal 250 Merger Corp (BRIV) | |
|---|---|---|---|---|
|
Cash From Operating Activities
|
-0.87 | -1.76 | -1.76 | -0.61 |
|
Cash Flow from Investing Activities
|
0.34 | -- | -236.90 | -- |
|
Cash from Financing Activities
|
-0.01 | 239.02 | 239.02 | 0.00 |
|
Net Cash Inflow / Outflow
|
-0.54 | -- | 0.36 | -0.61 |
Ratios
Profitability Ratios
| Intelligent Medicine Acquisition Corp (IQMD) | Kimbell Tiger Acquisition Corp (TGR-UN) | Kimbell Tiger Acquisition Corp (TGR) | B Riley Principal 250 Merger Corp (BRIV) | |
|---|---|---|---|---|
|
ROCE (%)
|
5.80 | 1.00 | 1.00 | 3.16 |
|
ROE (%)
|
4.91 | 2.18 | 1.69 | 3.21 |
|
ROA (%)
|
4.63 | 2.10 | 1.56 | 3.18 |
|
EBIT Margin (%)
|
-- | -- | -- | -- |
|
Net Margin (%)
|
114.93 | -- | 100.65 | 105.83 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- |
Growth Ratios
| Intelligent Medicine Acquisition Corp (IQMD) | Kimbell Tiger Acquisition Corp (TGR-UN) | Kimbell Tiger Acquisition Corp (TGR) | B Riley Principal 250 Merger Corp (BRIV) | |
|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | -- | -- | -- |
|
EBIT Growth (%)
|
1,391.00 | -- | -82.77 | -344.60 |
|
Net Profit Growth (%)
|
-100.00 | 409.41 | 498.84 | 90.91 |
|
EPS Growth (%)
|
-- | 4.09 | -- | 4.99 |
|
Book Value Growth (%)
|
-- | -42.53 | -- | -- |
Valuation Ratios
| Intelligent Medicine Acquisition Corp (IQMD) | Kimbell Tiger Acquisition Corp (TGR-UN) | Kimbell Tiger Acquisition Corp (TGR) | B Riley Principal 250 Merger Corp (BRIV) | |
|---|---|---|---|---|
|
Price / Earnings
|
-- | 116.04 | -- | 7.32 |
|
Price / Book Value
|
-- | 0.58 | -- | 0.23 |
|
Dividend Yield (%)
|
-- | -- | -- | -- |
|
EV/EBITDA
|
-- | 98.03 | -- | -6.83 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- |
Solvency Ratios
| Intelligent Medicine Acquisition Corp (IQMD) | Kimbell Tiger Acquisition Corp (TGR-UN) | Kimbell Tiger Acquisition Corp (TGR) | B Riley Principal 250 Merger Corp (BRIV) | |
|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.00 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.00 | 0.00 | 0.00 | 0.00 |
|
Current Ratio
|
0.17 | 25.11 | 25.11 | 1.43 |
|
Quick Ratio
|
0.17 | 25.11 | 25.11 | 1.43 |
|
Interest Coverage
|
1.62 | 1.60 | 1.50 | 2.21 |
Operating Efficiency Ratios
| Intelligent Medicine Acquisition Corp (IQMD) | Kimbell Tiger Acquisition Corp (TGR-UN) | Kimbell Tiger Acquisition Corp (TGR) | B Riley Principal 250 Merger Corp (BRIV) | |
|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | -- | -- | -- |
|
Asset Turnover
|
0.00 | 0.00 | 0.00 | 0.00 |
|
Receivable days
|
-- | -- | -- | -- |
|
Inventory Days
|
-- | -- | -- | -- |
|
Payable days
|
-- | -- | -- | 71.34 |
|
Cash Conversion Cycle
|
-- | -- | -- | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
